B
WVE icon

Bailard’s Wave Life Sciences WVE Stock Holding History

Bailard’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-85,000
Closed -$2.08M – 617
2019
Q3 		$1.75M Buy
85,000
+2,000
+2% +$45.9K 0.11% 167
2019
Q2 		$2.17M Buy
83,000
+41,000
+98% +$1.15M 0.13% 150
2019
Q1 		$1.63M Buy
42,000
+27,900
+198% +$1.13M 0.1% 177
2018
Q4 		$593K Sell
14,100
-6,600
-32% -$294K 0.04% 263
2018
Q3 		$1.03M Sell
20,700
-6,000
-22% -$271K 0.06% 213
2018
Q2 		$1.02M Sell
26,700
-26,000
-49% -$1.12M 0.06% 218
2018
Q1 		$2.11M Sell
52,700
-26,300
-33% -$1.11M 0.13% 159
2017
Q4 		$2.77M Buy
+79,000
New +$2.3M 0.17% 136

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bailard's WVE Position: Q4 2019 in Review

Bailard sold out of Wave Life Sciences (WVE) in Q4 2019, closing a stake of 85,000 shares — an estimated $2.08M sold.

Bailard first reported a position in WVE in Q4 2017 and held it in 8 quarters. The position peaked at $2.77M in Q4 2017. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2019.

  • Bailard reported no remaining Wave Life Sciences position as of Q4 2019 after selling out during the quarter.
  • Bailard sold 85,000 Wave Life Sciences shares in Q4 2019, an estimated $2.08M.
  • Bailard first reported a position in Wave Life Sciences in Q4 2017 and held it in 8 quarters.
  • Bailard's Wave Life Sciences position peaked at $2.77M in Q4 2017.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2019.

Based on Bailard's 13F filing for Q4 2019, filed 31 Jan 2020.